Filing Flows › Globus Medical (GMED) › Capital expenditures
Globus Medical (GMED) capital expenditures by quarter
Globus Medical's capital expenditures were $40.4M in Q3 2026 (third quarter 2026), +22% from Q2 2026. Over the last 7 quarters it ranged from $33.2M (Q2 2026) to $46.6M (Q2 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $40.4M | +22% | +13% |
| Q2 2026 | $33.2M | -16% | -29% |
| Q1 2026 | $39.6M | -14% | +10% |
| Q4 2025 | $46.2M | +29% | — |
| Q3 2025 | $35.8M | -23% | — |
| Q2 2025 | $46.6M | +29% | — |
| Q1 2025 | $36.1M | — | — |
Q3 2026 at a glance
Globus Medical, Q3 2026: revenue $764M (-0.7% year over year), operating margin 23.2%, net earnings $141M, operating cash flow $265M. The chart follows the revenue to costs, profit and cash.
Questions
What is Globus Medical's capital expenditures?
Globus Medical's capital expenditures were $40.4M in Q3 2026 (third quarter 2026), +22% from Q2 2026.
How has Globus Medical's capital expenditures changed?
Over the last 7 quarters it ranged from $33.2M (Q2 2026) to $46.6M (Q2 2025).